[1] AN Xiaoxia WANG Zhengang SU Chuanli LIU Kunrong LIAO Jin KANG Yi LI Min,.Study on The Clinical Effects of Qingwei Tongluo Recipe on Chronic Erosive Gastritis (CEG) with Precancerous Lesions (PLGC) Based on Collateral Disease Theory [J]. Modern Traditional Chinese Medicine, 2021, (05): 67-71. [doi: 10.13424/j.cnki.mtcm.2021.05.012]
Study on The Clinical Effects of Qingwei Tongluo Recipe on
Chronic Erosive Gastritis (CEG) with Precancerous
Lesions (PLGC) Based on Collateral Disease Theory
- Article number:
- 1672-0571(2021)05-0067-05
- Keywords:
- Qingwei Tongluo recipe; Chronic erosive gastritis; Precancerous lesions; Collateral disease of traditional Chinese Medicine
- ZTFLH:
- R256.3?
- Code:
- A
- Abstract:
- Objective To observe the clinical effect of Qingwei Tongluo Recipe on chronic erosivegastritis with precancerous lesions.Methods 80 cases of CEG with PLGC with damp heat blocking collaterals were randomly divided into two groups，44 cases in the treatment group and 36 cases in the control group.The control group was treated with Weifuchun tablets，and the treatment group was treated with Qingwei Tongluo recipe for 6 months.The TCM symptom score，endoscopic efficacy，pathological improvement (atrophy，intestinal metaplasia and dysplasia)，HP clearance rate，G-17，PGI，PGⅡand PGR were compared between the two groups before and after treatment.Results There were significant differences in clinical symptoms，endoscopic efficacy，pathological efficacy and HP clearance between the traditional Chinese medicine treatment group and the control group (P<0.05)；The levels of PGI and PGR in the two groups were higher than those before treatment (P<0.05)，and the treatment group was better than that in the control group (P<0.05)，and G-17 was also improved.Conclusion Qingwei Tongluo recipe based on the collateral disease theory of traditional Chinese medicine has a good overall clinical effect in the treatment of CEG with PLGC by clearing stomach，removing dampness，removing blood stasis and dredging collaterals.It can significantly improve the clinical symptoms and reverse the atrophy，intestinal metaplasia and dysplasia of gastric mucosa.
References:
［1］邹文斌,李兆申.中国胃癌发病率及死亡率研究进展\[J\].中国实用内科杂志,2014,34(4):408-415.
［2］孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析\[J\].中国肿瘤,2019,28(1):1-11.
［3］中华医学会消化病学分会.中国慢性胃炎共识意见（2012，上海）［J］.中国医学前沿杂志，2013，5(7)：44-55.
［4］周仲英．中医内科学［M］．北京：中国中医药出版社，2017：178-184．
［5］吴以岭．络病学［M］．北京：中国中医药出版社，2006：112-115．
［6］黄远程,潘静琳,黄超原,等.慢性萎缩性胃炎癌前病变证型、证素演变规律文献研究\[J\].中医杂志,2019,60(20):1778-1783.
［7］凌俊.窄带成像放大内镜在消化道早癌及癌前病变中的应用\[J\].系统医学,2019,4(15):72-74.
［8］李志红,田德禄.运用田德禄教授“清降”理论治疗功能性消化不良的经验\[J\].北京中医药大学学报(中医临床版),2013,20(2):45-46.
［9］马国琴,刘东玲.黄连药理研究进展\[J\].甘肃农业,2019(10):97-99.
［10］Wang N，Tan HY，Li L，et al.Berberine and Coptidis Rhizoma as potential anticancer agents:Recent updates and future perspectives\[J\].Journal of Ethnopharmacology，2015,176(24):35-48.
［11］田华,黄毓娟.蒲公英多糖对幽门螺杆菌相关性胃炎大鼠胃黏膜炎性反应及MAPK/ERK通路的影响\[J\].现代中西医结合杂志,2019,28(35):3877-3880.
［12］张博华,张义生.竹茹炮制研究进展\[J\].湖北中医杂志,2013,35(10):76-79.
［13］黄菊青.竹茹多糖的化学结构和免疫活性研究\[D\].杭州：浙江大学，2015.
［14］边文山.白花蛇舌草的抗肿瘤机制分析进展以及在血液病中的应用探析\[J\].临床医药文献电子杂志,2019,6(28):198.
［15］赵婕,伍朝霞,赵丽华.活血化瘀法治疗慢性萎缩性胃炎的临床研究\[J\].辽宁中医杂志,2014,41(11):2387-2389.
［16］李江虹,黄国进,成翠娥,等.智能染色内镜联合血清胃蛋白酶原、胃泌素-17检测在胃癌及癌前病变诊断中的价值\[J\].医学理论与实践,2019,32(22):3599-3601，3598.
［17］陈艳红,胡俊,李志晋,等.胃蛋白酶原联合FICE放大内镜对胃癌及癌前病变的诊断价值\[J\].实用癌症杂志,2019,34(10):1677-1679.
Memo
基金项目：广西壮族自治区卫健委科研项目（Z20180526）